Exosomes, a potential approach to enhance the therapeutic effects of traditional Chinese medicine

i

This article has been updated. A Correction to this article was published on .

i

The Original Article was published on

i

The Original Article was published on

i

This article has been updated

i

This article was retracted on

i

This article has been updated

Abstract

Traditional Chinese medicine (TCM) exerts unique therapeutic effects, while some unfavorable physicochemical properties limit its therapeutic potential. Exosomes are involved in cellular communication and may enhance the efficacy of TCM. The relationship between TCM and exosomes is supported by the connection between exosomes and the theory of “Qi, Xue and Ye” (one of the basic theories of TCM). Also, the functional resemblance between exosomes and Qi, which is less researched. We fill this gap by systematically summarizing exosomes from different sources with therapeutic effects and exploring the mechanisms and implications of exosomes in TCM treatment. TCM and exosomes undergo two-way communication, with TCM affecting exosomes and exosomes loading TCM monomers. The dual roles of exosomes as destructive agents in disease development are also emphasized; current obstacles and future scope of TCM–exosome therapeutic strategies are fully discussed. The objective of this review is to stimulate further investigation and create a new application of TCM.

Keywords

Traditional Chinese Medicine / Exosomes / TCM Formulas / TCM Monomers / Drug Delivery

CHANGE HISTORY

A Correction to this paper has been published:
https://doi.org

The Retraction Note was updated to reflect reception of statements of disagreement from all authors.

This article has been retracted.Please see the Retraction Notice for more detail:
https://doi.org

References

[1] Cao Y, Chen Y, Wang P, et al. Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency. Bioengineered. 2021; 12(2):10345-10362. https://doi.org/10.1080/21655979.2021.1996317.

[2] Gemmell JS, Lucke-Wold B . Traditional Chinese medicine and modern technology: network pharmacology and omics sequencing in gastric cancer. World J Gastrointest Oncol. 2025; 17(3):38-43. https://doi.org/10.4251/wjgo.v17.i3.102077.

[3] Wei D, Yang H, Zhang Y, et al. Nano-traditional Chinese medicine: a promising strategy and its recent advances. J Mater Chem B. 2022; 10(16):2973-2994. https://doi.org/10.1039/D2TB00225F.

[4] Tang H, Zhao X, Gong Y . Biological characteristics of exosomes and their applications in aquatic organisms. FASEB J. 2026; 40(4):e71601. https://doi.org/10.1096/fj.202504196R.

[5] Zhang Y, Liu Y, Liu H, et al. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9(1):19. https://doi.org/10.1186/s13578-019-0282-2.

[6] Yang X, Peng Y, Wang YE, et al. Curcumae Rhizoma exosomes-like nanoparticles loaded Astragalus components improve the absorption and enhance anti-tumor effect. J Drug Deliv Sci Technol. 2023; 81:104274. https://doi.org/10.1016/j.jddst.2023.104274.

[7] Ke SX . The principles of health, illness and treatment-the key concepts from “the yellow emperor’s classic of internal medicine”. J Ayurveda Integr Med. 2023; 14(1):100637. https://doi.org/10.1016/j.jaim.2022.100637.

[8] Zhang G, Liu H . Exploration of ascending-descending-exiting-entering in yi xue zhong zhong can xi lu: from classical philosophical theory to a novel diagnostic framework. Philos Ethics Humanit Med. 2026; 21(1):5. https://doi.org/10.1186/s13010-026-00212-7.

[9] Kocyla H. Basiswissen TCM: das system des xue. Z Ganzheitliche Tiermed. 2008; 22(04):143-148. https://doi.org/10.1055/s-2008-1039036.

[10] Zhang MY, Gao LY, Liu WL, et al. Research advances on extracellular vesicles-based regulation by traditional Chinese medicines and the relationship with TCM “Qi”. Acta Pharm Sin. 2023; 58(11):3222-3229. https://doi.org/10.16438/j.0513-4870.2023-0443.

[11] Xutian S, Zhang J, Louise W . New exploration and understanding of traditional Chinese medicine. Am J Chin Med. 2009; 37(03):411-426. https://doi.org/10.1142/s0192415x09006941.

[12] Yerrapragada SM, Bihl JC . Role of exosomes in mediating the cross-talk between adipose tissue and the brain. Neuromolecular Med. 2022; 24(2):57-61. https://doi.org/10.1007/s12017-021-08664-0.

[13] Li WW, Guo H, Wang XM . Relationship between endogenous hydrogen sulfide and blood stasis syndrome based on the Qi-blood theory of Chinese medicine. Chin J Integr Med. 2013; 19(9):701-705. https://doi.org/10.1007/s11655-013-1567-7.

[14] Mo C, Zhao J, Liang J, et al. Exosomes: a novel insight into traditional Chinese medicine. Front Pharmacol. 2022; 13:844782. https://doi.org/10.3389/fphar.2022.844782.

[15] Chen J, Chen J, Li Q, et al. Astragaloside promotes the secretion of MSC-derived exosomal miR-146a-5p by regulating TRAF6/NF-κB pathway to attenuate inflammation in high glucose-impaired endothelial cells. In Vitro Cell Dev Biol Anim. 2024; 61(1):93-106. https://doi.org/10.1007/s11626-024-00984-2.

[16] Kao SW, Hsu YT, Kuo WW, et al. Artemisia argyi-enhanced mesenchymal stem cell exosomes alleviates inflammation in C28/I2 chondrocytes by inhibiting NF-κB. Int J Med Sci. 2026; 23(3):1092-1104. https://doi.org/10.7150/ijms.126119.

[17] Pang C, Zhang J, Gu Y, et al. The biological roles of exosome-encapsulated traditional Chinese medicine monomers in neuronal disorders. J Pharm Anal. 2025; 15(5):101131. https://doi.org/10.1016/j.jpha.2024.101131.

[18] Salunkhe S, Dheeraj, Basak M, et al. Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: strategies and significance. J Control Release. 2020; 326:599-614. https://doi.org/10.1016/j.jconrel.2020.07.042.

[19] Li K, Ma L, Lu Z, et al. Apoptosis and heart failure: the role of non-coding RNAs and exosomal non-coding RNAs. Pathol Res Pract. 2023; 248:154669. https://doi.org/10.1016/j.prp.2023.154669.

[20] Heo JI, Ryu J . Exosomal noncoding RNA: a potential therapy for retinal vascular diseases. Mol Ther Nucleic Acids. 2024; 35(1):102128. https://doi.org/10.1016/j.omtn.2024.102128.

[21] Wang L, Pan Y, Liu M, et al. Wen-Shen-Tong-Luo-Zhi-Tong Decoction regulates bone-fat balance in osteoporosis by adipocyte-derived exosomes. Pharm Biol. 2023; 61(1):568-580. https://doi.org/10.1080/13880209.2023.2190773.

[22] Wei Y, Li M, Cui S, et al. Shikonin inhibits the proliferation of human breast cancer cells by reducing tumor-derived exosomes. Molecules. 2016; 21(6):777. https://doi.org/10.3390/molecules21060777.

[23] Li S. Tanshinone IIA enhances the therapeutic efficacy of mesenchymal stem cells derived exosomes in myocardial ischemia/reperfusion injury via up-regulating miR-223-5p. J Control Release. 2023; 358:13-26. https://doi.org/10.1016/j.jconrel.2023.04.014.

[24] Fadaei S, Zarepour F, Parvaresh M, et al. Epigenetic regulation in myocardial infarction: non-coding RNAs and exosomal non-coding RNAs. Front Cardiovasc Med. 2022; 9:1014961. https://doi.org/10.3389/fcvm.2022.1014961.

[25] Enright AJ, John B, Gaul U, et al. MicroRNA targets in Drosophila. Genome Biol. 2003; 5(1):R1. https://doi.org/10.1186/gb-2003-5-1-r1.

[26] Jasim SA, Al-Hawary SIS, Kaur I, et al. Critical role of exosome, exosomal non-coding RNAs and non-coding RNAs in head and neck cancer angiogenesis. Pathol Res Pract. 2024; 256:155238. https://doi.org/10.1016/j.prp.2024.155238.

[27] Wang D, Zhang W, Zhang C, et al. Exosomal non-coding RNAs have a significant effect on tumor metastasis. Mol Ther Nucleic Acids. 2022; 29:16-35. https://doi.org/10.1016/j.omtn.2022.05.034.

[28] Pisignano G, Michael DC, Visal TH, et al. Going circular: history, present, and future of circRNAs in cancer. Oncogene. 2023; 42(38):2783-2800. https://doi.org/10.1038/s41388-023-02780-w.

[29] Mirzadeh Azad F, Malakootian M, Mowla SJ . lncRNA PSORS1C3 is regulated by glucocorticoids and fine-tunes OCT4 expression in non-pluripotent cells. Sci Rep. 2019; 9(1):8370. https://doi.org/10.1038/s41598-019-44827-7.

[30] Si X, Zheng H, Wei G, et al. circRNA Hipk3 induces cardiac regeneration after myocardial infarction in mice by binding to Notch1 and miR-133a. Mol Ther Nucleic Acids. 2020; 21:636-655. https://doi.org/10.1016/j.omtn.2020.06.024.

[31] Tenchov R, Sasso JM, Wang X, et al. Exosomes-nature’s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano. 2022; 16(11):17802-17846. https://doi.org/10.1021/acsnano.2c08774.

[32] He F, Li WN, Li XX, et al. Exosome-mediated delivery of RBP-J decoy oligodeoxynucleotides ameliorates hepatic fibrosis in mice. Theranostics. 2022; 12(4):1816-1828. https://doi.org/10.7150/thno.69885.

[33] Kalluri R, LeBleu VS . The biology, function, and biomedical applications of exosomes. Science. 2020; 367(6478):eaau6977. https://doi.org/10.1126/science.aau6977.

[34] Tang Y, Zhou Y, Li HJ . Advances in mesenchymal stem cell exosomes: a review. Stem Cell Res Ther. 2021; 12(1):71. https://doi.org/10.1186/s13287-021-02138-7.

[35] Kang J, Hua P, Wu X, et al. Exosomes: efficient macrophage-related immunomodulators in chronic lung diseases. Front Cell Dev Biol. 2024; 12:1271684. https://doi.org/10.3389/fcell.2024.1271684.

[36] Zeng CY, Xu J, Liu X, et al. Cardioprotective roles of endothelial progenitor cell-derived exosomes. Front Cardiovasc Med. 2021; 8:717536. https://doi.org/10.3389/fcvm.2021.717536.

[37] Xu H, Li H, Zhang P, et al. The functions of exosomes targeting astrocytes and astrocyte-derived exosomes targeting other cell types. Neural Regen Res. 2024; 19(9):1947-1953. https://doi.org/10.4103/1673-5374.390961.

[38] Mei R, Wan Z, Yang C, et al. Advances and clinical challenges of mesenchymal stem cell therapy. Front Immunol. 2024; 15:1421854. https://doi.org/10.3389/fimmu.2024.1421854.

[39] Byun SE, Sim C, Chung Y, et al. Skeletal muscle regeneration by the exosomes of adipose tissue-derived mesenchymal stem cells. Cells Genes. 2021; 43(3):1473-1488. https://doi.org/10.3390/cimb43030104.

[40] Shang S, Wang J, Chen S, et al. Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer. Cancer Med. 2019; 8(18):7728-7740. https://doi.org/10.1002/cam4.2633.

[41] Wei Z, Hang S, Wiredu Ocansey DK, et al. Human umbilical cord mesenchymal stem cells derived exosome shuttling miR-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis. J Nanobiotechnol. 2023; 21(1):188. https://doi.org/10.1186/s12951-023-01951-x.

[42] Yang YH, Wen CS, Kuo YL, et al. GuiLu-ErXian glue extract promotes mesenchymal stem cells (MSC)-induced chondrogenesis via exosomes release and delays aging in the MSC senescence process. J Ethnopharmacol. 2023; 317:116784. https://doi.org/10.1016/j.jep.2023.116784.

[43] Chen M, Wang R, Liao L, et al. DanShen Decoction targets miR-93-5p to provide protection against MI/RI by regulating the TXNIP/NLRP3/caspase-1 signaling pathway. Phytomedicine. 2024; 135:156225. https://doi.org/10.1016/j.phymed.2024.156225.

[44] Liang J, Zhao J, Yang L, et al. MSC-exosomes pretreated by danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy. Stem Cell Res Ther. 2025; 16(1):40. https://doi.org/10.1186/s13287-025-04181-0.

[45] Hao M, Tao B, Luan Y, et al. Schisandrol A-loaded mesenchymal stem cell exosomes modulate FTO/miR-21/WNT5A axis to promote skin healing. Phytomedicine. 2025; 146:157088. https://doi.org/10.1016/j.phymed.2025.157088.

[46] Deng L, Jian Z, Xu T, et al. Macrophage polarization: an important candidate regulator for lung diseases. Molecules. 2023; 28(5):2379. https://doi.org/10.3390/molecules28052379.

[47] Song Y, Hu J, Ma C, et al. Macrophage-derived exosomes as advanced therapeutics for inflammation: current progress and future perspectives. Int J Nanomed. 2024; 19:1597-1627. https://doi.org/10.2147/IJN.S449388.

[48] Chen H, Han Z, Ma Y, et al. Advances in macrophage-derived exosomes as immunomodulators in disease progression and therapy. Int Immunopharmacol. 2024; 142:113248. https://doi.org/10.1016/j.intimp.2024.113248.

[49] Wang L, Yi X, Xiao X, et al. Exosomal miR-628-5p from M1 polarized macrophages hinders m6A modification of circFUT8 to suppress hepatocellular carcinoma progression. Cell Mol Biol Lett. 2022; 27(1):106. https://doi.org/10.1186/s11658-022-00406-9.

[50] Wang Y, Lin Q, Zhang H, et al. M2 macrophage-derived exosomes promote diabetic fracture healing by acting as an immunomodulator. Bioact Mater. 2023; 28:273-283. https://doi.org/10.1016/j.bioactmat.2023.05.018.

[51] Dai Y, Wang S, Chang S, et al. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway. J Mol Cell Cardiol. 2020; 142:65-79. https://doi.org/10.1016/j.yjmcc.2020.02.007.

[52] Cui L, Fan X, Xiao JL, et al. Exosomes from macrophages intervened by Jiedu Yangxin Decoction mediated endothelial-to-mesenchymal transition to improve myocardial fibrosis after myocardial infarction. Br J Pharmacol. 2026:bph.70398. https://doi.org/10.1111/bph.70398.

[53] Liang M, Zhu X, Zhang D, et al. Yi-shen-hua-shi Granules inhibit diabetic nephropathy by ameliorating podocyte injury induced by macrophage-derived exosomes. Front Pharmacol. 2022; 13:962606. https://doi.org/10.3389/fphar.2022.962606.

[54] Li Q, Zhu S, Chen G, et al. Exosomal miR-10b derived from protocatechuic acid-treated efferocytic macrophages inhibits endothelial inflammation by targeting MAP3K7/β-TrCP/NF-κB signaling pathway. Phytomedicine. 2026; 153:157939. https://doi.org/10.1016/j.phymed.2026.157939.

[55] Zhou S, Gao B, Sun C, et al. Vascular endothelial cell-derived exosomes protect neural stem cells against ischemia/reperfusion injury. Neuroscience. 2020; 441:184-196. https://doi.org/10.1016/j.neuroscience.2020.05.046.

[56] Zhang Y, Qin Y, Chopp M, et al. Ischemic cerebral endothelial cell-derived exosomes promote axonal growth. Stroke. 2020; 51(12):3701-3712. https://doi.org/10.1161/STROKEAHA.120.031728.

[57] Cheng P, Xie X, Hu L, et al. Hypoxia endothelial cells-derived exosomes facilitate diabetic wound healing through improving endothelial cell function and promoting M2 macrophages polarization. Bioact Mater. 2024; 33:157-173. https://doi.org/10.1016/j.bioactmat.2023.10.020.

[58] Huang J, Zhang G, Li S, et al. Endothelial cell-derived exosomes boost and maintain repair-related phenotypes of Schwann cells via miR199-5p to promote nerve regeneration. J Nanobiotechnol. 2023; 21(1):10. https://doi.org/10.1186/s12951-023-01767-9.

[59] Li P, Hong G, Zhan W, et al. Endothelial progenitor cell derived exosomes mediated miR-182-5p delivery accelerate diabetic wound healing via down-regulating PPARG. Int J Med Sci. 2023; 20(4):468-481. https://doi.org/10.7150/ijms.78790.

[60] Pan J, Wu TT, Chen B, et al. Exosomes derived from endothelial progenitor cells ameliorate glyoxylate deprivation (OGD)-induced neuronal apoptosis by delivering miR-221-3p. Histol Histopathol. 2022; 38(04):423-430. https://doi.org/10.14670/HH-18-528.

[61] Xiong W, Huang XL, Li CY, et al. Astragaloside IV-mediated endothelial progenitor cell exosomes promote autophagy and inhibit apoptosis in hyperglycemic damaged endothelial cellsvia miR-21/PTEN axis. Folia Histochem Cytobiol. 2022; 60(4):323-334. https://doi.org/10.5603/FHC.a2022.0030.

[62] Lin CM, Wang BW, Pan CM, et al. Chrysin boosts KLF2 expression through suppression of endothelial cell-derived exosomal microRNA-92a in the model of atheroprotection. Eur J Nutr. 2021; 60(8):4345-4355. https://doi.org/10.1007/s00394-021-02593-1.

[63] Kalani A, Kamat PK, Chaturvedi P, et al. Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia. Life Sci. 2014; 107(1-2):1-7. https://doi.org/10.1016/j.lfs.2014.04.018.

[64] Hasel P, Liddelow SA . Astrocytes. Curr Biol. 2021; 31(7):R326-R327. https://doi.org/10.1016/j.cub.2021.01.056.

[65] Upadhya R, Zingg W, Shetty S, et al. Astrocyte-derived extracellular vesicles: neuroreparative properties and role in the pathogenesis of neurodegenerative disorders. J Control Release. 2020; 323:225-239. https://doi.org/10.1016/j.jconrel.2020.04.017.

[66] D PMR González E, Lillo C, Ganfornina MD, et al. Extracellular vesicles secreted by astroglial cells transport apolipoprotein D to neurons and mediate neuronal survival upon oxidative stress. Front Cell Neurosci. 2019; 12:00526. https://doi.org/10.3389/fncel.2018.00526.

[67] Sun R, Liao W, Lang T, et al. Astrocyte-derived exosomal miR-378a-5p mitigates cerebral ischemic neuroinflammation by modulating NLRP3-mediated pyroptosis. Front Immunol. 2024; 15:1454116. https://doi.org/10.3389/fimmu.2024.1454116.

[68] Li J, Xu H, Zhang K, et al. Astrocyte-derived exosomes-transported miRNA-26a-5p ameliorates sevoflurane-induced cognitive dysfunction in aged mice. Transl Res. 2024; 268:79-96. https://doi.org/10.1016/j.trsl.2024.01.007.

[69] He X, Huang Y, Liu Y, et al. Astrocyte-derived exosomal lncRNA 4933431K23Rik modulates microglial phenotype and improves post-traumatic recovery via SMAD7 regulation. Mol Ther. 2023; 31(5):1313-1331. https://doi.org/10.1016/j.ymthe.2023.01.031.

[70] Ding W, Gu Q, Liu M, et al. Astrocytes-derived exosomes pre-treated by berberine inhibit neuroinflammation after stroke via miR-182-5p/Rac1 pathway. Int Immunopharmacol. 2023; 118:110047. https://doi.org/10.1016/j.intimp.2023.110047.

[71] Ou J, Zhou Y, Li C, et al. Sinomenine protects against morphine dependence through the NMDAR1/CAMKII/CREB pathway: a possible role of astrocyte-derived exosomes. Molecules. 2018; 23(9):2370. https://doi.org/10.3390/molecules23092370.

[72] Wei W, Li H, Deng Y, et al. The combination of Alisma and Atractylodes ameliorates cerebral ischaemia/reperfusion injury by negatively regulating astrocyte-derived exosomal miR-200a-3p/141-3p by targeting SIRT1. J Ethnopharmacol. 2023; 313:116597. https://doi.org/10.1016/j.jep.2023.116597.

[73] Lang T, Qin K, Shao L, et al. Glycosides of Buyang Huanwu Decoction alleviate cerebral infarction injury by inhibiting neuronal pyroptosis via astrocyte-derived exosomal miR-378b_L + 1. J Ethnopharmacol. 2025; 352:120234. https://doi.org/10.1016/j.jep.2025.120234.

[74] Barzin M, Bagheri AM, Ohadi M, et al. Application of plant-derived exosome-like nanoparticles in drug delivery. Pharm Dev Technol. 2023; 28(5):383-402. https://doi.org/10.1080/10837450.2023.2202242.

[75] Cheng J, Zhu Y . Review on extraction technology and function of plant-derived exosome-like nanoparticles. Front Med Technol. 2025; 7:1668738. https://doi.org/10.3389/fmedt.2025.1668738.

[76] Kim JS, Lee HJ, Yoon EJ, et al. Protective effect of Iris germanica L. rhizome-derived exosome against oxidative-stress-induced cellular senescence in human epidermal keratinocytes. Appl Sci. 2023; 13(21):11681. https://doi.org/10.3390/app132111681.

[77] Kim J, Li S, Zhang S, et al. Plant-derived exosome-like nanoparticles and their therapeutic activities. Asian J Pharm Sci. 2022; 17(1):53-69. https://doi.org/10.1016/j.ajps.2021.05.006.

[78] Xie Q, Gu J, Sun Y, et al. Therapeutic potential of ginger exosome-like nanoparticles for alleviating periodontitis-induced tissue damage. Int J Nanomed. 2024; 19:11941-11956. https://doi.org/10.2147/IJN.S483091.

[79] Xu M, Ma L, Liang H, et al. Protective effects of small RNAs encapsulated in Artemisia capillaris-derived exosomes against non-alcoholic fatty liver disease. Front Pharmacol. 2025; 15:1476820. https://doi.org/10.3389/fphar.2024.1476820.

[80] Wang T, Zhao J, Li QY, et al. Poria cocos-derived exosome-like nanovesicles alleviate metabolic dysfunction-associated fatty liver disease by promoting mitophagy and inhibiting NLRP3 inflammasome activation. Int J Mol Sci. 2025; 26(5):2253. https://doi.org/10.3390/ijms26052253.

[81] Liu M, Wang T, Fu J, et al. Pinellia exosomal vesicles remodulate tumor-associated macrophage polarization via the serine synthesis/JAK/STAT signaling pathway to inhibit lung cancer growth. Phytomedicine. 2026; 151:157759. https://doi.org/10.1016/j.phymed.2025.157759.

[82] Xu S, Zhang Z, Zhou X, et al. Gouqi-derived nanovesicles (GqDNVs) promoted MC3T3-E1 cells proliferation and improve fracture healing. Phytomedicine. 2025; 142:156755. https://doi.org/10.1016/j.phymed.2025.156755.

[83] Zhou X, Xu S, Zhang Z, et al. Gouqi-derived nanovesicles (GqDNVs) inhibited dexamethasone-induced muscle atrophy associating with AMPK/SIRT1/PGC1α signaling pathway. J Nanobiotechnology. 2024; 22(1):276. https://doi.org/10.1186/s12951-024-02563-9.

[84] Yang S, Li W, Bai X, et al. Ginseng-derived nanoparticles alleviate inflammatory bowel disease via the TLR4/MAPK and p62/Nrf2/Keap1 pathways. J Nanobiotechnology. 2024; 22(1):48. https://doi.org/10.1186/s12951-024-02313-x.

[85] Yang S, Lu S, Ren L, et al. Ginseng-derived nanoparticles induce skin cell proliferation and promote wound healing. J Ginseng Res. 2023; 47(1):133-143. https://doi.org/10.1016/j.jgr.2022.07.005.

[86] Yang S, Guo J, Chen D, et al. The cardioprotective effect of ginseng derived exosomes via inhibition of oxidative stress and apoptosis. ACS Appl Bio Mater. 2025; 8(1):814-824. https://doi.org/10.1021/acsabm.4c01644.

[87] Khalid W, Aslam A, Ahmed N, et al. Human plasma-derived exosomes: a promising carrier system for the delivery of hydroxyurea to combat breast cancer. AAPS PharmSciTech. 2025; 26(1):42. https://doi.org/10.1208/s12249-024-03028-w.

[88] Timofeeva AM, Paramonik AP, Sedykh SS, et al. Milk exosomes: next-generation agents for delivery of anticancer drugs and therapeutic nucleic acids. Int J Mol Sci. 2023; 24(12):10194. https://doi.org/10.3390/ijms241210194.

[89] Weng R, Li X, Zhao J, et al. Circulating exosomal miR-20b-5p and miR-1273g-3p were potential biomarkers for diagnosis and prognosis of acute coronary syndrome. Cardiovasc Diagn Ther. 2025; 15(6):1149-1160. https://doi.org/10.21037/cdt-2025-368.

[90] Wang W, Wang Z, Wang F, et al. Exosomes from young healthy human plasma ameliorate sepsis-induced cardiomyopathy by inhibiting ferroptosis via the miR-3130-3p/LPCAT3 axis. Free Radic Biol Med. 2026; 246:140-158. https://doi.org/10.1016/j.freeradbiomed.2026.01.012.

[91] Bae IS, Kim SH . Exosome-derived miR-11987 in bovine milk inhibits obesity through browning of white fat. Int J Mol Sci. 2025; 26(13):6006. https://doi.org/10.3390/ijms26136006.

[92] Guo L, Huang Z, Huang L, et al. Surface-modified engineered exosomes attenuated cerebral ischemia/reperfusion injury by targeting the delivery of quercetin towards impaired neurons. J Nanobiotechnology. 2021; 19(1):141. https://doi.org/10.1186/s12951-021-00879-4.

[93] Qi Y, Guo L, Jiang Y, et al. Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles. Drug Deliv. 2020; 27(1):745-755. https://doi.org/10.1080/10717544.2020.1762262.

[94] Wang Y, Zhao L, Yuan W, et al. A natural membrane vesicle exosome-based sinomenine delivery platform for hepatic carcinoma therapy. Curr Top Med Chem. 2021; 21(14):1224-1234. https://doi.org/10.2174/1568026621666210612032004.

[95] Zhuang X, Xiang X, Grizzle W, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther. 2011; 19(10):1769-1779. https://doi.org/10.1038/mt.2011.164.

[96] González-Sarrías A, Iglesias-Aguirre CE, Cortés-Martín A, et al. Milk-derived exosomes as nanocarriers to deliver curcumin and resveratrol in breast tissue and enhance their anticancer activity. Int J Mol Sci. 2022; 23(5):2860. https://doi.org/10.3390/ijms23052860.

[97] Agrawal AK, Aqil F, Jeyabalan J, et al. Milk-derived exosomes for oral delivery of paclitaxel. Nanomedicine. 2017; 13(5):1627-1636. https://doi.org/10.1016/j.nano.2017.03.001.

[98] Wang M, Yan M, Tan L, et al. Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis. Front Pharmacol. 2024; 15:1337623. https://doi.org/10.3389/fphar.2024.1337623.

[99] Liu G, Tan L, Zhao X, et al. Anti-atherosclerosis mechanisms associated with regulation of non-coding RNAs by active monomers of traditional Chinese medicine. Front Pharmacol. 2023; 14:1283494. https://doi.org/10.3389/fphar.2023.1283494.

[100] Wen J, Liu J, Wan L, et al. Long noncoding RNA/circular RNA regulates competitive endogenous RNA networks in rheumatoid arthritis: molecular mechanisms and traditional Chinese medicine therapeutic significances. Ann Med. 2023; 55(1):973-989. https://doi.org/10.1080/07853890.2023.2172605.

[101] Meng L. Treating cancer through modulating exosomal protein loading and function: the prospects of natural products and traditional Chinese medicine. Pharmacol Res. 2024; 203:107179. https://doi.org/10.1016/j.phrs.2024.107179.

[102] Chen Y, Li Y, Wu Y, et al. Yiwei Decoction promotes apoptosis of gastric cancer cells through spleen-derived exosomes. Front Pharmacol. 2023; 14:1144955. https://doi.org/10.3389/fphar.2023.1144955.

[103] Gao Y, Shen S, Wang Y, et al. Organ crosstalk: the role of spleen. Phenomics . 2024; 5(2):192-207. https://doi.org/10.1007/s43657-023-00147-5.

[104] Jia WT, Xiang S, Zhang JB, et al. Jiedu Recipe, a compound Chinese herbal medicine, suppresses hepatocellular carcinoma metastasis by inhibiting the release of tumor-derived exosomes in a hypoxic microenvironment. J Integr Med. 2024; 22(6):696-708. https://doi.org/10.1016/j.joim.2024.10.002.

[105] Chen Y, Liu J, Chen Y, et al. Jianpi Yangzheng Xiaozheng Decoction alleviates gastric cancer progression via suppressing exosomal PD-L1. Front Pharmacol. 2023; 14:1159829. https://doi.org/10.3389/fphar.2023.1159829.

[106] Chen J, Zhou Q, Lu Y . Saponins from Panax notoginseng ameliorate steroid resistance in lupus nephritis through regulating lymphocyte-derived exosomes in mice. Front Pharmacol. 2022; 13:946392. https://doi.org/10.3389/fphar.2022.946392.

[107] Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010; 18(9):1606-1614. https://doi.org/10.1038/mt.2010.105.

[108] Wu Q, Dong QQ, Wang SH, et al. Tumor cell-derived exosomal hybrid nanosystems loaded with rhubarbic acid and tanshinone IIA for sepsis treatment. J Inflamm Res. 2024; 17:5093-5112. https://doi.org/10.2147/JIR.S457978.

[109] Aqil F, Munagala R, Jeyabalan J, et al. Exosomes for the enhanced tissue bioavailability and efficacy of curcumin. AAPS J. 2017; 19(6):1691-1702. https://doi.org/10.1208/s12248-017-0154-9.

[110] Liang L, Zhao L, Wang Y, et al. Treatment for hepatocellular carcinoma is enhanced when norcantharidin is encapsulated in exosomes derived from bone marrow mesenchymal stem cells. Mol Pharm. 2021; 18(3):1003-1013. https://doi.org/10.1021/acs.molpharmaceut.0c00976.

[111] Yang Y, Ren S, Huang W, et al. Camptothecin delivery via tumor-derived exosome for radiosensitization by cell cycle regulation on patient-derived xenograft mice. Front Bioeng Biotechnol. 2022; 10:876641. https://doi.org/10.3389/fbioe.2022.876641.

[112] Kim MS, Haney MJ, Zhao Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine. 2016; 12(3):655-664. https://doi.org/10.1016/j.nano.2015.10.012.

[113] Chen C, Shen M, Wan X, et al. Activated T cell-derived exosomes for targeted delivery of AXL-siRNA loaded paclitaxel-poly-L-lysine prodrug to overcome drug resistance in triple-negative breast cancer. Chem Eng J. 2023; 468:143454. https://doi.org/10.1016/j.cej.2023.143454.

[114] Rao Q, Ma G, Li M, et al. Targeted delivery of triptolide by dendritic cell-derived exosomes for colitis and rheumatoid arthritis therapy in murine models. Br J Pharmacol. 2023; 180(3):330-346. https://doi.org/10.1111/bph.15958.

[115] Lu Y, Zhou H, Han C, et al. Enhanced therapeutic impact of shikonin-encapsulated exosomes in the inhibition of colorectal cancer progression. Nanotechnology. 2024; 35(41):415101. https://doi.org/10.1088/1361-6528/ad61f2.

[116] Deng C, Zhang H, Li Y, et al. Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis therapy. J Colloid Interface Sci. 2024; 671:354-373. https://doi.org/10.1016/j.jcis.2024.05.162.

[117] Lu M, Lou A, Gao J, et al. Quercetin-primed MSC exosomes synergistically attenuate osteoarthritis progression. J Orthop Surg Res. 2025; 20(1):373. https://doi.org/10.1186/s13018-025-05785-1.

[118] Zhao B, Zheng J, Qiao Y, et al. Prostatic fluid exosome-mediated microRNA-155 promotes the pathogenesis of type IIIA chronic prostatitis. Transl Androl Urol. 2021; 10(5):1976-1987. https://doi.org/10.21037/tau-21-139.

[119] Yang J, Tan Y, Zhou G . T cell-derived exosomes containing cytokines induced keratinocytes apoptosis in oral lichen planus. Oral Dis. 2022; 28(3):682-690. https://doi.org/10.1111/odi.13795.

[120] Shieh TM, Lin NC, Shen YW, et al. Epithelium-derived exosomal dipeptidyl peptidase-4 involved in arecoline-induced oral submucous fibrosis. Biochim Biophys Acta Mol Basis Dis. 2025; 1871(3):167683. https://doi.org/10.1016/j.bbadis.2025.167683.

[121] Chen Y, Li J, Zhang X, et al. Mesenteric adipose-derived exosomal TINAGL1 enhances intestinal fibrosis in Crohn’s diseasevia SMAD4. J Adv Res. 2025; 70:139-158. https://doi.org/10.1016/j.jare.2024.05.016.

[122] Jiang T, Xu C, Gao S, et al. Cathepsin L-containing exosomes from α-synuclein-activated microglia induce neurotoxicity through the P2X7 receptor. NPJ Parkinsons Dis. 2022; 8(1):127. https://doi.org/10.1038/s41531-022-00394-9.

[123] Winston CN, Aulston B, Rockenstein EM, et al. Neuronal exosome-derived human tau is toxic to recipient mouse neurons in vivo . J Alzheimers Dis. 2019; 67(2):541-553. https://doi.org/10.3233/JAD-180776.

[124] Zhang H, Xing J, Dai Z, et al. Exosomes: the key of sophisticated cell-cell communication and targeted metastasis in pancreatic cancer. Cell Commun Signal. 2022; 20(1):9. https://doi.org/10.1186/s12964-021-00808-w.

[125] Lu Y, Han G, Zhang Y, et al. M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma. Cell Commun Signal. 2023; 21(1):299. https://doi.org/10.1186/s12964-022-00872-w.

[126] Nicolini A, Ferrari P, Biava PM . Exosomes and cell communication: from tumour-derived exosomes and their role in tumour progression to the use of exosomal cargo for cancer treatment. Cancers. 2021; 13(4):822. https://doi.org/10.3390/cancers13040822.

[127] Hu X, Mu Y, Liu J, et al. Exosomes derived from hypoxic colorectal cancer cells transfer miR-410-3p to regulate tumor progression. J Cancer. 2020; 11(16):4724-4735. https://doi.org/10.7150/jca.33232.

[128] Zhou L, Zhang T, Shao W, et al. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release. Skelet Muscle. 2021; 11(1):17. https://doi.org/10.1186/s13395-021-00274-5.

[129] Cai X, Wang Z, Lin S, et al. Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma. Phytomedicine. 2024; 126:155402. https://doi.org/10.1016/j.phymed.2024.155402.

[130] Jiang B, Yang J, Huang Q, et al. Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth. Front Pharmacol. 2025; 16:1547685. https://doi.org/10.3389/fphar.2025.1547685.

[131] Dai X, Hu Y, Sun C, et al. Qizhu Jianwei Decoction triggers ferroptosis by exosome-mediated miR-199-3p/ACSL4 signaling pathways. J Ethnopharmacol. 2025; 344:119529. https://doi.org/10.1016/j.jep.2025.119529.

[132] Tomasetti M, Gaetani S, Monaco F, et al. Epigenetic regulation of miRNA expression in malignant mesothelioma: miRNAs as biomarkers of early diagnosis and therapy. Front Oncol. 2019; 9:1293. https://doi.org/10.3389/fonc.2019.01293.

[133] Baer C, Claus R, Plass C . Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res. 2013; 73(2):473-477. https://doi.org/10.1158/0008-5472.CAN-12-3731.

[134] Mu N, Li J, Zeng L, et al. Plant-derived exosome-like nanovesicles: current progress and prospects. Int J Nanomed. 2023; 18:4987-5009. https://doi.org/10.2147/IJN.S420748.

[135] Li Y, Wang Y, Zhao H, et al. Engineering strategies of plant-derived exosome-like nanovesicles: current knowledge and future perspectives. Int J Nanomed. 2024; 19:12793-12815. https://doi.org/10.2147/IJN.S496664.

[136] Zuo Y, Zhang J, Wang X, et al. Plant-derived exosome-like nanovesicles: dual-function platforms for anticancer therapy and drug delivery. J Transl Med. 2026; 24(1):77. https://doi.org/10.1186/s12967-025-07657-y.

[137] Yang T, He M, Huang J, et al. From garden to clinic: plant-derived exosome-like nanovesicles for precision oxidative stress therapy. Int J Nanomed. 2025; 20:15569-15598. https://doi.org/10.2147/IJN.S569204.

[138] Guan B, Zhang S, Wei Y, et al. Chinese herbal medicine-derived nanovesicles for combatting cancers. Nanomedicine. 2026; 71:102888. https://doi.org/10.1016/j.nano.2025.102888.

[139] He J, Ren W, Wang W, et al. Exosomal targeting and its potential clinical application. Drug Deliv Transl Res. 2022; 12(10):2385-2402. https://doi.org/10.1007/s13346-021-01087-1.

[140] Tao H, Gao B . Exosomes for neurodegenerative diseases: diagnosis and targeted therapy. J Neurol. 2024; 271(6):3050-3062. https://doi.org/10.1007/s00415-024-12329-w.

[141] Jiang L, Gu Y, Du Y, et al. Engineering exosomes endowed with targeted delivery of triptolide for malignant melanoma therapy. ACS Appl Mater Interfaces. 2021; 13(36):42411-42428. https://doi.org/10.1021/acsami.1c10325.

[142] Ding YN, Li MQ, Song JY, et al. Engineered exosomes improve the effects of curcumin on protecting mitochondria of neurons in Alzheimer’s disease. Mater Today Bio. 2025; 32:101738. https://doi.org/10.1016/j.mtbio.2025.101738.

[143] Choi H, Choi Y, Yim HY, et al. Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes. Tissue Eng Regen Med. 2021; 18(4):499-511. https://doi.org/10.1007/s13770-021-00361-0.

[144] Zhang S, Cheng Z, Wang Y, et al. The risks of miRNA therapeutics: in a drug target perspective. Drug Des Devel Ther. 2021; 15:721-733. https://doi.org/10.2147/DDDT.S288859.

[145] Chen Q, Wu D, Wang Y, et al. Exosomes as novel delivery systems for application in traditional Chinese medicine. Molecules. 2022; 27(22):7789. https://doi.org/10.3390/molecules27227789.

[146] Zhang GK, Zhou F . Exosomes loaded with traditional Chinese medicine constituents: a novel therapeutic avenue for aplastic anemia. Chin Med. 2026; 21(1):53-73. https://doi.org/10.1186/s13020-026-01330-2.

[147] Song QY, Cui YJ, Lu WP . Isolation of exosome-like nanovesicles from Yiqi Huoxue Jiedu decoction and their anti-ovarian cancer activity. Front Pharmacol. 2025; 16:1680551. https://doi.org/10.3389/fphar.2025.1680551.